This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Taiwan Liposome Co., Ltd., Tlc Biopharmaceuticals, Inc.. Active years: 2026.
Company Filing History:
1 out of 2 
1 out of 32 Years Active: 2026
Title: Hsin-Yi Chiu: Innovator in Liposomal Therapeutics
Introduction
Hsin-Yi Chiu is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of liposomal sustained-release compositions. His innovative work aims to enhance therapeutic efficacy while minimizing side effects.
Latest Patents
Hsin-Yi Chiu holds a patent for a liposomal sustained-release composition containing a therapeutic drug. This composition comprises a therapeutic agent and one or more lipids, which are present at a predetermined ratio. The formulation is designed to achieve a desired therapeutic effect while avoiding undesired side effects. The therapeutic agent is stably entrapped in the liposomes, allowing for sustainable release. This innovative liposomal formulation demonstrates an improved release profile for the therapeutic agent.
Career Highlights
Throughout his career, Hsin-Yi Chiu has worked with notable companies in the biopharmaceutical sector. He has been associated with Tlc Biopharmaceuticals, Inc. and Taiwan Liposome Co., Ltd. His work in these organizations has contributed to advancements in drug delivery systems and therapeutic applications.
Collaborations
Hsin-Yi Chiu has collaborated with various professionals in his field, including his coworker Yun-Long Tseng, who has also made significant contributions to pharmaceutical research.
Conclusion
Hsin-Yi Chiu's innovative work in liposomal therapeutics exemplifies the potential of targeted drug delivery systems. His contributions continue to influence the development of effective therapeutic solutions.